Hydroxychloroquine for COVID19: The curtains close on a comedy of errors - The Lancet Regional Health – Americas
►https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(22)00085-0/fulltext
With dozens of trials now published, we can finally close the curtains on hydroxychloroquine for COVID-19.
Ultimately, hydroxychloroquine did not have clinical benefit for COVID-19. The efforts of the trialists and the goodwill of patients who volunteered for the studies should not be diminished, but lessons extricated from this fiasco must galvanize us to do better in the next pandemic.